id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_4pians4wmfbzrm4zcnygnl4hze	Li Zhang	Randomized double-blind trial of prophylactic topical Evozac® Calming Skin Spray for gefitinib-associated acne-like eruption	2014.0	6	.pdf	application/pdf	4540	937	71	effect of Evozac Calming Skin Spray on the prevention of rash in patients receiving gefitinib. Methods: Non-small-cell lung cancer patients preparing to initiate gefitinib therapy were randomly assigned to apply Evozac Calming Skin Spray or physiological saline to the face Calming Skin Spray group than in the physiological saline group at the end of 1 week (0.25 versus Skin Spray group also developed fewer facial lesions at the end of 2 weeks and 4 weeks, however, the difference was not statistically significant. the Evozac Calming Skin Spray group developed rash of grade 2 or greater severity (17.6% vs Conclusion: Prophylactic treatment with Evozac Calming Skin Spray appears to decrease the to examine the role of Evozac Calming Skin Spray in managing skin side effects induced by EGFR inhibitors. lesions between Evozac Calming Skin Sprayand physiological saline-treated patients at completion of the study total, 51 patients in the Evozac Calming Skin Spray group 	./cache/work_4pians4wmfbzrm4zcnygnl4hze.pdf	./txt/work_4pians4wmfbzrm4zcnygnl4hze.txt